Literature DB >> 27601633

PAXX and XLF DNA repair factors are functionally redundant in joining DNA breaks in a G1-arrested progenitor B-cell line.

Vipul Kumar1, Frederick W Alt2, Richard L Frock1.   

Abstract

Classical nonhomologous end joining (C-NHEJ) is a major mammalian DNA double-strand break (DSB) repair pathway. Core C-NHEJ factors, such as XRCC4, are required for joining DSB intermediates of the G1 phase-specific V(D)J recombination reaction in progenitor lymphocytes. Core factors also contribute to joining DSBs in cycling mature B-lineage cells, including DSBs generated during antibody class switch recombination (CSR) and DSBs generated by ionizing radiation. The XRCC4-like-factor (XLF) C-NHEJ protein is dispensable for V(D)J recombination in normal cells, but because of functional redundancy, it is absolutely required for this process in cells deficient for the ataxia telangiectasia-mutated (ATM) DSB response factor. The recently identified paralogue of XRCC4 and XLF (PAXX) factor has homology to these two proteins and variably contributes to ionizing radiation-induced DSB repair in human and chicken cells. We now report that PAXX is dispensable for joining V(D)J recombination DSBs in G1-arrested mouse pro-B-cell lines, dispensable for joining CSR-associated DSBs in a cycling mouse B-cell line, and dispensable for normal ionizing radiation resistance in both G1-arrested and cycling pro-B lines. However, we find that combined deficiency for PAXX and XLF in G1-arrested pro-B lines abrogates DSB joining during V(D)J recombination and sensitizes the cells to ionizing radiation exposure. Thus, PAXX provides core C-NHEJ factor-associated functions in the absence of XLF and vice versa in G1-arrested pro-B-cell lines. Finally, we also find that PAXX deficiency has no impact on V(D)J recombination DSB joining in ATM-deficient pro-B lines. We discuss implications of these findings with respect to potential PAXX and XLF functions in C-NHEJ.

Entities:  

Keywords:  C-NHEJ; DNA repair; PAXX; V(D)J recombination; XLF

Mesh:

Substances:

Year:  2016        PMID: 27601633      PMCID: PMC5035843          DOI: 10.1073/pnas.1611882113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair.

Authors:  Valentyn Oksenych; Frederick W Alt; Vipul Kumar; Bjoern Schwer; Duane R Wesemann; Erica Hansen; Harin Patel; Arthur Su; Chunguang Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Transcription-associated processes cause DNA double-strand breaks and translocations in neural stem/progenitor cells.

Authors:  Bjoern Schwer; Pei-Chi Wei; Amelia N Chang; Jennifer Kao; Zhou Du; Robin M Meyers; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-12       Impact factor: 11.205

Review 3.  V(D)J recombination: mechanisms of initiation.

Authors:  David G Schatz; Patrick C Swanson
Journal:  Annu Rev Genet       Date:  2011-08-19       Impact factor: 16.830

4.  DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.

Authors:  Takashi Ochi; Andrew N Blackford; Julia Coates; Satpal Jhujh; Shahid Mehmood; Naoka Tamura; Jon Travers; Qian Wu; Viji M Draviam; Carol V Robinson; Tom L Blundell; Stephen P Jackson
Journal:  Science       Date:  2015-01-09       Impact factor: 47.728

5.  Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development.

Authors:  Xiangyu Liu; Wenxia Jiang; Richard L Dubois; Kenta Yamamoto; Zachary Wolner; Shan Zha
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

6.  A mechanism for the suppression of homologous recombination in G1 cells.

Authors:  Alexandre Orthwein; Sylvie M Noordermeer; Marcus D Wilson; Sébastien Landry; Radoslav I Enchev; Alana Sherker; Meagan Munro; Jordan Pinder; Jayme Salsman; Graham Dellaire; Bing Xia; Matthias Peter; Daniel Durocher
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

Review 7.  Mechanisms of programmed DNA lesions and genomic instability in the immune system.

Authors:  Frederick W Alt; Yu Zhang; Fei-Long Meng; Chunguang Guo; Bjoern Schwer
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

8.  Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway.

Authors:  Mengtan Xing; Mingrui Yang; Wei Huo; Feng Feng; Leizhen Wei; Wenxia Jiang; Shaokai Ning; Zhenxin Yan; Wen Li; Qingsong Wang; Mei Hou; Chunxia Dong; Rong Guo; Ge Gao; Jianguo Ji; Shan Zha; Li Lan; Huanhuan Liang; Dongyi Xu
Journal:  Nat Commun       Date:  2015-02-11       Impact factor: 14.919

9.  Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells.

Authors:  Pei-Chi Wei; Amelia N Chang; Jennifer Kao; Zhou Du; Robin M Meyers; Frederick W Alt; Bjoern Schwer
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

10.  Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

Authors:  Gang Li; Frederick W Alt; Hwei-Ling Cheng; James W Brush; Peter H Goff; Mike M Murphy; Sonia Franco; Yu Zhang; Shan Zha
Journal:  Mol Cell       Date:  2008-09-05       Impact factor: 17.970

View more
  45 in total

1.  DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions.

Authors:  Rohit A Panchakshari; Xuefei Zhang; Vipul Kumar; Zhou Du; Pei-Chi Wei; Jennifer Kao; Junchao Dong; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  Phosphorylation at S2053 in Murine (S2056 in Human) DNA-PKcs Is Dispensable for Lymphocyte Development and Class Switch Recombination.

Authors:  Wenxia Jiang; Verna M Estes; Xiaobin S Wang; Zhengping Shao; Brian J Lee; Xiaohui Lin; Jennifer L Crowe; Shan Zha
Journal:  J Immunol       Date:  2019-05-17       Impact factor: 5.422

Review 3.  XLF/Cernunnos: An important but puzzling participant in the nonhomologous end joining DNA repair pathway.

Authors:  Vijay Menon; Lawrence F Povirk
Journal:  DNA Repair (Amst)       Date:  2017-08-18

Review 4.  The molecular basis and disease relevance of non-homologous DNA end joining.

Authors:  Bailin Zhao; Eli Rothenberg; Dale A Ramsden; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2020-10-19       Impact factor: 94.444

Review 5.  Nonhomologous DNA end-joining for repair of DNA double-strand breaks.

Authors:  Nicholas R Pannunzio; Go Watanabe; Michael R Lieber
Journal:  J Biol Chem       Date:  2017-12-14       Impact factor: 5.157

Review 6.  The recent advances in non-homologous end-joining through the lens of lymphocyte development.

Authors:  Xiaobin S Wang; Brian J Lee; Shan Zha
Journal:  DNA Repair (Amst)       Date:  2020-06-25

7.  An in vivo study of the impact of deficiency in the DNA repair proteins PAXX and XLF on development and maturation of the hemolymphoid system.

Authors:  Stefania Musilli; Vincent Abramowski; Benoit Roch; Jean-Pierre de Villartay
Journal:  J Biol Chem       Date:  2020-01-08       Impact factor: 5.157

8.  Absence of XRCC4 and its paralogs in human cells reveal differences in outcomes for DNA repair and V(D)J recombination.

Authors:  Brian Ruis; Amy Molan; Taylor Takasugi; Eric A Hendrickson
Journal:  DNA Repair (Amst)       Date:  2019-11-12

9.  Deficiency of XLF and PAXX prevents DNA double-strand break repair by non-homologous end joining in lymphocytes.

Authors:  Putzer J Hung; Bo-Ruei Chen; Rosmy George; Caleb Liberman; Abigail J Morales; Pedro Colon-Ortiz; Jessica K Tyler; Barry P Sleckman; Andrea L Bredemeyer
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

Review 10.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.